CME in Minutes: Education in Ophthalmology - David S. Boyer, MD - An Eye Toward Improving Adherence: Easing the DME Treatment Burden With Longer-Acting Anti-VEGF Agents

David S. Boyer, MD - An Eye Toward Improving Adherence: Easing the DME Treatment Burden With Longer-Acting Anti-VEGF Agents

08/23/23 • 14 min

CME in Minutes: Education in Ophthalmology

Please visit answersincme.com/YYB860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in ophthalmology discusses strategies for selecting anti-VEGF therapy and maintaining adherence for patients with diabetic macular edema. Upon completion of this activity, participants should be better able to: Describe guideline-concordant, evidence-based strategies to select appropriate therapy for patients with diabetic macular edema (DME); Review the clinical profiles of longer-acting vascular endothelial growth factor (VEGF)-targeted agents with phase 3 trial evidence in the treatment of DME; and Outline patient-centered management approaches to improve adherence to VEGF-targeted therapy.

Previous Episode

W. Lloyd Clark, MD - The Urgency of Retinal Vein Occlusion: Timely Detection, Referral, and Management

Please visit answersincme.com/MUP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in ophthalmology discusses the importance of early detection and referral of patients with retinal vein occlusion (RVO), as well as a personalized and multidisciplinary approach to management. Upon completion of this activity, participants should be better able to: Recognize the rationale for early detection of RVO; Describe the appropriate processes for timely referral of patients with RVO; and Outline strategies for personalized, multidisciplinary management of patients with RVO.

Next Episode

undefined - Diana V. Do, MD / Michael A. Singer, MD - An Eye Toward Improving Outcomes in DME: Timely Diagnosis and Reduced Treatment Burden With Longer-Acting Anti-VEGF Agents

Diana V. Do, MD / Michael A. Singer, MD - An Eye Toward Improving Outcomes in DME: Timely Diagnosis and Reduced Treatment Burden With Longer-Acting Anti-VEGF Agents

Please visit answersincme.com/YSM860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in ophthalmology discuss timely diagnosis of diabetic macular edema (DME) and treatment with anti–vascular endothelial growth factor (VEGF) agents. Upon completion of this activity, participants should be better able to: Recognize best practices to achieve a prompt and accurate diagnosis of DME; Describe guideline-concordant, evidence-based strategies to select appropriate therapy for patients with DME; and Review the clinical profiles of longer-acting VEGF-targeted agents with phase 3 trial evidence in the treatment of DME.